Loading stock analysis…
Evidence Synthesis
Last synthesized: 4 Sept 2026, 13:06
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Market Update: MAPROIN Sees Significant Improvement in Gross Margin MAPROIN (MAPROIN) reported a substantial acceleration in its gross margin, rising to 100% in the latest quarter, a notable improvement from 27.09% in the previous quarter.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | 27.09 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 27.09 % | 136.32 | ▼ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 650 shares | 28,702 | ▼ |
| CLOSE_PRICE | 50.83 INR | 50.83 | - |